甲状腺激素受体β抑制乳腺癌干细胞自我更新能力
该研究探讨甲状腺激素受体β(TRβ)对乳腺癌干细胞(CSC)的影响,采用表达TRβ的MCF-7细胞在贴壁或 mammosphere 培养及免疫缺陷小鼠接种模型。结果显示三碘甲状腺原氨酸(T3)处理显著减少CD44+/CD24-和ALDH+亚群、 mammosphere 形成效率、极限稀释实验中的CSC自我更新能力、多能性因子表达及肿瘤起始能力,并降低迁移和侵袭。转录组分析显示T3下调雌激素受体α(ERα)及ER响应基因。结论提示TRβ在CSC生物学中起新作用,可能与其作为乳腺癌抑癌因子相关。
要点
- T3处理表达TRβ的MCF-7细胞减少CD44+/CD24-和ALDH+细胞亚群。
- T3降低 mammosphere 形成效率及极限稀释实验中的CSC自我更新能力。
- T3下调ERα及ER响应基因,并减少免疫缺陷小鼠中的肿瘤起始能力。
核心结论
- TRβ在乳腺癌干细胞生物学中具有新作用,可能与其抑癌功能相关。
研究设计与样本
- 使用表达TRβ的MCF-7细胞(MCF7-TRβ)在贴壁或 mammosphere 条件下培养,并接种免疫缺陷小鼠。
主要发现
- T3处理显著减少CD44+/CD24-和ALDH+细胞亚群。
- T3降低 mammosphere 形成效率及极限稀释实验中CSC的自我更新能力。
- T3降低 mammosphere 中多能性因子表达及免疫缺陷小鼠中的肿瘤起始能力。
- T3减少迁移和侵袭。
- 转录组分析显示T3下调ERα和ER响应基因,且T3抑制基因中富集含管腔型乳腺癌关键转录因子结合位点的基因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: A subpopulation of cancer stem cells (CSCs) with capacity for self-renewal is believed to drive initiation, progression, and relapse of breast tumors. Methods: Since the thyroid hormone receptor β (TRβ) appears to suppress breast tumor growth and metastasis, we have analyzed the possibility that TRβ could affect the CSC population using MCF-7 cells grown under adherent conditions or as mammospheres, as well as inoculation into immunodeficient mice. Results: Treatment of TRβ-expressing MCF-7 cells (MCF7-TRβ cells) with the thyroid hormone triiodothyronine (T3) decreased significantly CD44+/CD24- and ALDH+ cell subpopulations, the efficiency of mammosphere formation, the self-renewal capacity of CSCs in limiting dilution assays, the expression of the pluripotency factors in the mammospheres, and tumor initiating capacity in immunodeficient mice, indicating that the hormone reduces the CSC population present within the bulk MCF7-TRβ cultures. T3 also decreased migration and invasion, a hallmark of CSCs. Transcriptome analysis showed downregulation of the estrogen receptor alpha (ERα) and ER-responsive genes by T3. Furthermore, among the T3-repressed genes, there was an enrichment in genes containing binding sites for transcription factors that are key determinants of luminal-type breast cancers and are required for ER binding to chromatin. Conclusion: We demonstrate a novel role of TRβ in the biology of CSCs that may be related to its action as a tumor suppressor in breast cancer.
引用
- López-Mateo I, Alonso-Merino E, Suarez-Cabrera C, et al. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells. Thyroid. 2019. PMID: 31760908. doi:10.1089/thy.2019.0175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。